News

Pharmabiz1h
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients: Miami Saturday, August 2, 2025, 18:00 Hrs [IST] Pasith ...
Pharmabiz2h
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...
Pharmabiz3h
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery: Irvine, California Saturday, August 2, 2025, 16:00 Hrs [IST ...
Pharmabiz3h
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi: Our Bureau, Mumbai Saturday, August 2, 2025, 15:40 Hrs [IST] Marengo Asi ...
Pharmabiz3h
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation
A new UK Health Security Agency study - Effectiveness of RSV Vaccine Against RSV Associated Hospitalisation Among Adults Aged 75 to 79 years in England - in partnership with Nottingham University ...
Pharmabiz4h
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...
Pharmabiz5h
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US: Houston Saturday, August 2, 2025, 14:00 Hrs [IST] Plus Therapeutics, Inc., a cli ...
Pharmabiz6h
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...
Pharmabiz7h
Medicenna strengthens IP portfolio with five patents granted for its IL-2 and IL-4 Superkines
US Patent No. 12,202,873 – Superagonists, Partial Agonists and Antagonists of IL-2. Also granted in Switzerland, China, Germany, France, United Kingdom, India, and Japan and allowed in Canada with ...
Pharmabiz8h
US FDA requires major changes to opioid pain medication labelling to emphasize risks
US FDA requires major changes to opioid pain medication labelling to emphasize risks: Maryland Saturday, August 2, 2025, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Pharmabiz10h
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader: Dublin Saturday, August 2, 2025, 09:00 Hrs [IST] Mallinckrodt plc, a leading provide ...
Pharmabiz11h
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...